Associated Papers
Tumor DNA from tumor in situ fluid was used to track evolution of glioma under first-line treatment.
Yu J et al.
Frontiers in Oncology, 2025
41179686 (PubMed )
Supplement: Table2.xls › Sheet1
Genotype-negative multiple endocrine neoplasia type 1 with prolactinoma, hyperparathyroidism, and subclinical Cushing's syndrome accompanied by hyperglycemia: a case report.
Kubo H et al.
Frontiers in Endocrinology, 2024
UMD-MEN1 Database: An Overview of the 370 MEN1 Variants Present in 1676 Patients From the French Population.
Romanet P et al.
The Journal of Clinical Endocrinology and Metabolism, 2019
Co-occurrence of MEN1 p.Gly111fs and AIP p.Arg16His Variants in Familial MEN1 Phenotype.
DE Melo FM et al.
Anticancer Research, 2018
Genetic analysis of parathyroid and pancreatic tumors in a patient with multiple endocrine neoplasia type 1 using whole-exome sequencing.
Kim BY et al.
Bmc Medical Genetics, 2017
A Novel Inherited Mutation in PRKAR1A Abrogates PreRNA Splicing in a Carney Complex Family.
Sun Y et al.
The Canadian Journal of Cardiology, 2015
Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4).
Thakker RV
Molecular and Cellular Endocrinology, 2014
Alterations of MEN1 and E-cadherin/β-catenin complex in sporadic pulmonary carcinoids.
Veschi S et al.
International Journal of Oncology, 2012
Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene.
Lemos MC et al.
Human Mutation, 2008
Multiple endocrine neoplasia type 1 (MEN1) gene mutations in a subset of patients with sporadic and familial primary hyperparathyroidism target the coding sequence but spare the promoter region.
Karges W et al.
The Journal of Endocrinology, 2000
Select a paper to view details